The main event of PBC's first boxing card on FOX as part of a revamped broadcast deal is in jeopardy after Willie Monroe Jr. was notified of an adverse finding on a drug test.
The Voluntary Anti-Doping Association (VADA) and the WBC announced that it has found an adverse finding coming from a urine sample taken in early November. Monroe is scheduled to fight interim WBC middleweight titleholder Jermall Charlo in the main event of the December 22 PBC on FOX card from the Barclays Center in Brooklyn, New York.
Below is the announcement of the adverse finding from WBC President Maurico Sulaiman. The governing body stated that it will make a ruling on December 17 that could decide the fate of the fight against Charlo.
.@WBCBoxing has been confirmed by @Vada_Testing that Willie Monroe tested with an adverse finding. All parties have been informed. @premierboxing @TGBpromotions & @FOXSports are all in agreement of making the best to preserve the safety of all in boxing. WBC will rule on monday.
— Mauricio Sulaiman (@wbcmoro) December 15, 2018
Although no specifics on the adverse finding was announced, ESPN's Steve Kim reported that Monroe tested positive for testosterone in a urine exam done on November 3.
The rest of the televised portion of the PBC card remains intact with Charlo's brother Jermell defending the WBC junior middleweight title against Tony Harrison in the co-main event. The opening fight will be a heavyweight bout between Dominic Breazeale and Carlos Negron.
